SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders watching guidance, subscriber engagement and advertising growth after a steep share-price decline and recent layoffs and content-leadership changes. Views are split between hopes for a rebound if results or outlook exceed subdued expectations and bets on further losses if growth concerns persist.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas sharp selloff and fresh low are being linked by traders to plans for a potential Monee listing and the launch of Sea Cloud, alongside concerns about spending and competition in e-commerce. Some see a Monee separation as value-unlocking, while others view the plans and uncertainty around them as a reason to sell; claims of further undisclosed bad news remain speculation.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel data in progressive MS and additional BRIUMVI results, with commercial growth and a future subcutaneous formulation also part of the bullish case. Traders are anticipating a catalyst-driven move, though some caution that the azer-cel results remain uncertain and complain that the shares have struggled to break out of a trading range.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally has sparked breakout talk, with traders pointing to rising momentum, chart patterns, and the tokens limited supply; others remain skeptical, calling it a volatile bounce and questioning whether gains can hold.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

RAP-219s Phase 2 trial in bipolar mania met its primary and secondary endpoints, prompting bullish trading and analyst optimism, including an upgrade. The community is divided over the modest placebo-adjusted benefit and concerns about agitation and discontinuations; the initial surge faded as traders debated whether the data justify further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

REnergy Dynamics (RED) Enters into a Strategic Alliance with GMM Pfaudler to Manufacture Paddle Agitators Under the ‘Make in India’ Initiative

New Delhi [India], September 25: REnergy Dynamics (RED), a company dedicated to advancing the bioenergy sector in India, has entered into a strategic alliance with GMM Pfaudler, a global leader in technologies, systems, and services, to become one of the first companies in India to manufacture paddle agitators under the Government's 'Make in India' initiative.

3M India appoints Aseem Joshi as President and Managing Director (designate)

Prior to this appointment, Joshi served as CEO, India Business, at GMM Pfaudler

GMM Pfaudler Ltd (BOM:505255) Q1 2026 Earnings Call Highlights: Strong India Growth and ...

GMM Pfaudler Ltd (BOM:505255) Q1 2026 Earnings Call Highlights: Strong India Growth and Strategic Acquisitions Drive Profitability

GMM Pfaudler reports stable revenue, improved margins in Q1 FY26

GMM Pfaudler Limited reported stable revenue of 795 crores for the first quarter of fiscal year 2026, while achieving a 14% year-on-year increase in consolidated EBITDA driven by strong performance in India

Technical Breakouts: SEBI Analyst Bets On Archidply, GMM Pfaudler, And Two More Chemical Stocks 

Equity

Classic signals like the golden crossover and morning star add conviction to these midcap picks.


GMM Pfaudler Ltd. engages in the design, manufacture, and market of chemical processing equipment, which are used in the pharmaceutical, specialty chemicals, agro chemicals, and chemical processing industries. It operates through the following business segments: Glass Lined Equipment; Heavy Engineering; Mixing Systems; Engineered Systems & Acid Recovery; and Filtration and Drying. The firm also offers flouro-polymer products and other equipment such as agitated nutsche filters, filter driers, and wiped film evaporators. The company was founded on November 17, 1962 and is headquartered in Mumbai, India.

GMM Pfaudler Ltd.

Bearish Sentiment

Bullish technical indicators are signalling potential in four midcap stocks from the chemicals and manufacturing space. SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Vinaytaparia">Vinay Taparia</a> is betting on Archidply Industries, GMM Pfaudler, Alkyl Amines Chemicals, and Thirumalai Chemicals, but cautions that key supports must hold for his outlook to remain valid.&nbsp;Let’s take a look at his recommendations:&nbsp;Archidply Industries&nbsp;<a href="https://stocktwits.com/symbol/ARCHIDPLY.NSE">Archidply</a> has given a good breakout on the daily chart. Its Relative Strength Index (RSI) is also suggesting strength. The stock can move to ₹140 levels in the next six to nine months. He expects ₹105 to act as a support, but a close below ₹97 negates this outlook.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623141724</stembedurl>GMM Pfaudler<a href="https://stocktwits.com/symbol/GMMPFAUDLR.NSE">GMM Pfaudler</a> has given a good breakout. The stock has recently formed a golden crossover as well. It can move to ₹1,600-₹1,800 level in the next six to nine months, but a close below ₹1,260 invalidates this view.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623140471</stembedurl>Alkyl Amines Chemicals<a href="https://stocktwits.com/symbol/ALKYLAMINE.NSE">Alkyl Amines</a> has given a channel breakout on the daily chart.&nbsp; It is trading above the 50 and 200-day Exponential Moving Averages (EMAs). The stock can move to ₹2,700 in the next six to nine months, but a close below ₹2,090 negates the outlook.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623138956</stembedurl>Thirumalai Chemicals&nbsp;<a href="https://stocktwits.com/symbol/TIRUMALCHM.NSE">Thirumalai Chemicals</a> stock has formed a morning star pattern on the support line. It can move to ₹320-₹340 in the short term. But a close below ₹277 negates this view.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623137613</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Classic signals like the golden crossover and morning star add conviction to these midcap picks.

Current Price	1,292.00
Prev Close	1,308.10
Open	1,306.00
Dividend Yield	0.25%
50-Day Moving Average	1,253.55
Beta	-0.06
Avg. Volume	576,647.24
PE Ratio	77.74

52-Week High	1,533.60
52-Week Low	735.00
Market Capitalization	57.95B
EPS (Annual)	12.86
Price to Book	4.81
Revenue Per Employee	34.35M

Feed

News

Sentiment

Fundamentals

Info

GMMPFAUDLR.NSE Fundamentals